SEC Form 4 · accession 0001209191-17-033108
AtriCure, Inc. · ATRC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Elizabeth D Krell
Director
Period of report
May 16, 2017
Accepted (ET)
May 17, 2017 · 4:35 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001323885
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 16, 2017 | M | 10,000 | $10.10 | A | 24,162 | D | |
| Common StockF1 | May 17, 2017 | S | 10,000 | $21.44 | D | 14,162 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $10.10 | May 16, 2017 | M | 10,000 | D | May 28, 2009 | May 28, 2018 | Common Stock | 10,000 | 0 | D |
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $21.37 to $21.65 per share. The price reported above reflects the weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F2These options were granted on May 28, 2008 and are exercisable cumulatively at a rate of 33% per annum beginning one year from date of grant.